NCT05010902 Pregnancy Cohort in Multiple Sclerosis (MS)
| NCT ID | NCT05010902 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Multiple Sclerosis (MS) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2013-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2013-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multiple sclerosis (MS) is a common inflammatory demyelinating disorder of the central nervous system frequently affecting females in their reproductive phase of life. In this prospective observational study, we obtain data on the outcome of pregnancies in MS patients and the influence of pregnancy on clinical, laboratory and MRI parameters in MS.
Eligibility Criteria
Inclusion Criteria: * age \> 18 years * signed informed consent * diagnosis of multiple sclerosis or clinically isolated syndrome Exclusion Criteria: * clinically relevant comorbidities * contraindications for MRI, e.g. pacemaker, metal implants, allergy against gadolinium * alcohol or drug abuse
Contact & Investigator
Nadja Siebert, MD
✉ nadja.siebert@charite.deNadja Siebert, MD
PRINCIPAL INVESTIGATOR
Experimental & Clinical Research Unit, Charité Universitätsmedizin Berlin
Frequently Asked Questions
Who can join the NCT05010902 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Multiple Sclerosis (MS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05010902 currently recruiting?
Yes, NCT05010902 is actively recruiting participants. Contact the research team at nadja.siebert@charite.de for enrollment information.
Where is the NCT05010902 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT05010902 clinical trial?
NCT05010902 is sponsored by Charite University, Berlin, Germany. The principal investigator is Nadja Siebert, MD at Experimental & Clinical Research Unit, Charité Universitätsmedizin Berlin. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.